SYRS
Syros Pharmaceuticals, Inc. · Healthcare
Arch Venture Fund Vii, L.P. sold $1.3M of Syros Pharmaceuticals, Inc.
10% owner
Sold$1,312,380
$7.83Price
167,503Shares
−4%Stake
What SYRS did after the filing
Prices for SYRS after this filing aren't in yet.
Traded Tue, Mar 12. Filed Thu, Mar 14, 2:57 PM ET, during the session. Not investment advice.